🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Manual Therapy on Oral Opening, Swallow Function and Upper Quarter Mobility on Head and Neck Cancer Survivors

RecruitingNAAges 18 Years - anyAllUniversidad de La Frontera
NCT06148077 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Trismus has been reported as the second most common comorbidity in survivors of head and neck cancer (HNC). It is mainly associated with post-radiotherapy subcutaneous fibrosis, muscular atrophy, damage to neurological structures in the neck, or a combination of all, affecting masticatory musculature. In addition to this, the loss of flexibility and strength in the shoulder has also been shown to be related to deficits in the function and quality of life of these patients. The goal of this clinical trial is to determinate the effectiveness and safety of Manual Therapy (MT) on Oral Opening, Swallow Function, as well as the mobility of the upper quarter, the strength of cervical musculature, pain, functionality, and the perception of quality of life in head and neck cancer survivors. Participants will be assigned randomly to the study groups: a) manual therapy program and control motor e

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * individuals with HNC * individuals over 18 years of age * individuals who have undergone oncological surgery of the head and neck and/or radiotherapy * having finished oncological medical treatment between 3 and 36 months before inclusion * having a medical diagnosis of trismus and/or TMD and/or cervical or shoulder dysfunction * Spanish native speakers Exclusion Criteria: * sequelae of previous stroke * structural instability and/or osteoporosis of the cervical spine, spondylosis, cervical herniated discs * active osteoradionecrosis or open wounds (fistulas, soft tissue necrosis) in the anatomical treatment area * tracheostomized individuals * metastasis or active cancer * refuse to participate.
💊

What it tests

  • Manual Therapy
  • Motor control exercises
📍

Where

2 sites
Barbara Burgos Mansilla
Temuco, Chile
Universidad de La Frontera
Temuco, Chile
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy